Header Logo

Connection

DAVID GRAHAM to Esophagus

Back to Details
This is a "connection" page, showing publications DAVID GRAHAM has written about Esophagus.
DAVID GRAHAM
Connection Strength
0.984
Esophagus
  1. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-?B activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. Int J Exp Pathol. 2018 02; 99(1):10-14.
    View in: PubMed
    Score: 0.124
  2. Reply to Kristo et al. Endoscopy. 2016 Jan; 48(1):93.
    View in: PubMed
    Score: 0.107
  3. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy. 2015 Nov; 47(11):980-7.
    View in: PubMed
    Score: 0.103
  4. Manometry in classic and vigorous achalasia. Gastroenterology. 1992 Dec; 103(6):1993.
    View in: PubMed
    Score: 0.086
  5. Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population. Dig Dis Sci. 2011 Mar; 56(3):761-6.
    View in: PubMed
    Score: 0.075
  6. A new endoscopic method for managing food impaction in the esophagus. Endoscopy. 1990 Sep; 22(5):226-8.
    View in: PubMed
    Score: 0.074
  7. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 1989 Mar; 96(3):683-9.
    View in: PubMed
    Score: 0.067
  8. Esophageal motor abnormality during hiccup. Gastroenterology. 1986 Jun; 90(6):2039.
    View in: PubMed
    Score: 0.055
  9. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol. 2003 Jul; 98(7):1462-70.
    View in: PubMed
    Score: 0.045
  10. Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc. 2001 Oct; 54(4):448-53.
    View in: PubMed
    Score: 0.040
  11. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001 May; 96(5):1378-82.
    View in: PubMed
    Score: 0.039
  12. Alendronate gastric ulcers. Aliment Pharmacol Ther. 1999 Apr; 13(4):515-9.
    View in: PubMed
    Score: 0.034
  13. Endoscopy under gnotobiotic conditions: a unique experience. Gastrointest Endosc. 1978 Nov; 24(6):298-9.
    View in: PubMed
    Score: 0.033
  14. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol. 1997 Aug; 92(8):1322-5.
    View in: PubMed
    Score: 0.030
  15. Guidewire-assisted esophageal dilation. Gastrointest Endosc. 1991 Nov-Dec; 37(6):650-1.
    View in: PubMed
    Score: 0.020
  16. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
    View in: PubMed
    Score: 0.013
  17. Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am J Gastroenterol. 2003 Jun; 98(6):1266-70.
    View in: PubMed
    Score: 0.011
  18. Bougienage is effective therapy for most benign esophageal strictures. JAMA. 1978 Sep 01; 240(9):844-7.
    View in: PubMed
    Score: 0.008
  19. The columnar-cell-lined (Barrett's) esophagus: a premalignant condition? South Med J. 1977 Apr; 70(4):505-7.
    View in: PubMed
    Score: 0.007
  20. Esophageal motor dysfunction in systemic diseases. Arch Intern Med. 1976 May; 136(5):583-8.
    View in: PubMed
    Score: 0.007
  21. Infectious esophagitis. Gastrointest Endosc Clin N Am. 1994 Oct; 4(4):713-29.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.